Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50375794 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_474267 (CHEMBL935072) | ||
IC50 | 0.75±n/a nM | ||
Citation | Chen, MH; Fitzgerald, P; Singh, SB; O'Neill, EA; Schwartz, CD; Thompson, CM; O'Keefe, SJ; Zaller, DM; Doherty, JB Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors. Bioorg Med Chem Lett18:2222-6 (2008) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50375794 | |||
n/a | |||
Name | BDBM50375794 | ||
Synonyms: | CHEMBL409901 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H24Cl3N3O3 | ||
Mol. Mass. | 556.867 | ||
SMILES | Clc1ccccc1-c1cc(OCCNC(=O)[C@@H]2CCCN2)cc2n(-c3c(Cl)cccc3Cl)c(=O)ccc12 |wU:16.16,(24.63,-15.07,;23.3,-15.85,;23.3,-17.38,;21.96,-18.16,;20.63,-17.39,;20.63,-15.85,;21.97,-15.08,;21.97,-13.54,;23.3,-12.77,;23.3,-11.23,;24.63,-10.45,;25.97,-11.22,;27.3,-10.45,;28.64,-11.21,;28.61,-12.75,;27.21,-13.5,;29.93,-13.53,;30.06,-15.07,;31.52,-15.39,;32.33,-14.07,;31.33,-12.91,;21.97,-10.47,;20.64,-11.23,;19.31,-10.46,;19.31,-8.91,;17.99,-8.15,;16.66,-8.92,;17.99,-6.61,;19.32,-5.83,;20.66,-6.6,;20.66,-8.14,;21.99,-8.92,;17.98,-11.23,;16.65,-10.47,;17.98,-12.78,;19.31,-13.54,;20.64,-12.77,)| | ||
Structure |